Literature DB >> 2921361

Discrepant toxoplasma latex agglutination test results.

R E Holliman1, J Johnson, K Duffy, L New.   

Abstract

The analysis of 4450 toxoplasma serology results showed that 59 (1.3%) latex agglutination reactions were not confirmed in the dye test. These discrepant results were associated with an unspecified IgM antibody but not associated with kit batch variation, inactivation of sera, concurrent cytomegalovirus infection, or the presence of hepatitis B virus "e" antigen. The latex agglutination test is useful as a screen for toxoplasma infection but false positive reactions do occur. Patients at risk of severe toxoplasmosis should be investigated by additional tests.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2921361      PMCID： PMC1141827          DOI： 10.1136/jcp.42.2.200

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  10 in total

1.  Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasite (Toxoplasma).

Authors:  A B Sabin; H A Feldman
Journal:  Science       Date:  1948-12-10       Impact factor: 47.728

2.  [Natural antibodies against Toxoplasma].

Authors:  G Desmonts; H Baufine-Ducrocq; P Couzineau; Y Peloux
Journal:  Nouv Presse Med       Date:  1974-06-15

3.  False positive results with heated sera in Toxoplasma ELISA for IgG antibody.

Authors:  J M Francis; R A Payne; D H Joynson; A H Balfour
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

4.  Cytomegalovirus complement-fixing IgM antibody.

Authors:  J C Booth; G Hannington; Y Tryhorn; H Stern
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

5.  Comparison of a latex agglutination test with other serological tests for the measurement of antibodies to Toxoplasma gondii.

Authors:  R A Payne; J M Francis; W Kwantes
Journal:  J Clin Pathol       Date:  1984-11       Impact factor: 3.411

6.  Comparative study of three tests (dye test, indirect haemagglutination test, latex agglutination test) for the detection of antibodies to Toxoplasma gondii in human sera.

Authors:  A H Balfour; D G Fleck; H P Hughes; D Sharp
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

7.  Toxoplasmosis in Panama: a 10-year study.

Authors:  O E Sousa; R E Saenz; J K Frenkel
Journal:  Am J Trop Med Hyg       Date:  1988-03       Impact factor: 2.345

8.  Eosinophilic infiltrates of the gastrointestinal tract.

Authors:  A J Blackshaw; D A Levison
Journal:  J Clin Pathol       Date:  1986-01       Impact factor: 3.411

9.  Detection of IgM antibodies against cytomegalovirus: comparison of two radioimmunoassays, enzyme-linked immunosorbent assay and immunofluorescent antibody test.

Authors:  H O Kangro; J C Booth; T M Bakir; Y Tryhorn; S Sutherland
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

10.  Enzyme-linked immunosorbent assay (ELISA) using antibody class capture for the detection of antitoxoplasma IgM.

Authors:  R A Payne; M Isaac; J M Francis
Journal:  J Clin Pathol       Date:  1982-08       Impact factor: 3.411
  10 in total
  10 in total

1.  Laboratory techniques in the investigation of toxoplasmosis.

Authors:  K F Barker; R E Holliman
Journal:  Genitourin Med       Date:  1992-02

2.  Serological study of the prevalence of toxoplasmosis in asymptomatic patients infected with human immunodeficiency virus.

Authors:  R E Holliman
Journal:  Epidemiol Infect       Date:  1990-10       Impact factor: 2.451

3.  Selective antenatal screening for toxoplasmosis and the latex agglutination test.

Authors:  R E Holliman; K F Barker; J D Johnson
Journal:  Epidemiol Infect       Date:  1990-10       Impact factor: 2.451

4.  Evaluation of five commercial assays for screening antenatal sera for antibodies to Toxoplasma gondii.

Authors:  W D Cubitt; A E Ades; C S Peckham
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

5.  Direct agglutination test and other assays for measuring antibodies to Toxoplasma gondii.

Authors:  J Johnson; K Duffy; L New; R E Holliman; B S Chessum; D G Fleck
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

6.  Evaluation of Toxoplasma gondii propagated in specific pathogen free embryonated chicken egg, for diagnosis of toxoplasmosis in equids and human.

Authors:  Abeer M Abdalhamed; Mohey A Hassanain; Gamil S G Zeedan; Raafat M Shaapan
Journal:  J Parasit Dis       Date:  2019-04-13

7.  Assessment of immunoglobulin-M immunosorbent agglutination assay (ISAGA) for detecting toxoplasma specific IgM.

Authors:  K T Duffy; P J Wharton; J D Johnson; L New; R E Holliman
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

8.  Incidence of toxoplasmosis in patients with glandular fever and in healthy blood donors.

Authors:  J D Johnson; R E Holliman
Journal:  Br J Gen Pract       Date:  1991-09       Impact factor: 5.386

9.  Serological Investigation of Bovine Toxoplasmosis Using Commercial and Indigenous ELISA Kits While Validating Cattle Toxo IgG ELISA Kit.

Authors:  Haroon Akbar; Muhammad Zubair Shabbir; Ubaid Ullah; Muhammad Imran Rashid
Journal:  Animals (Basel)       Date:  2022-08-14       Impact factor: 3.231

10.  Development and assessment of a latex agglutination test based on recombinant MSP5 to detect antibodies against Anaplasma marginale in cattle.

Authors:  Carlos A N Ramos; Flábio R Araújo; Rafaelle C Santos; Elaine S P Melo; Letícia C Sousa; Carlos E S Vidal; Neurisvan R Guerra; Rafael A N Ramos
Journal:  Braz J Microbiol       Date:  2014-05-02       Impact factor: 2.476
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.